Pancreatic Cancer Action Network (PanCAN) Company Profile

Background

Founded in 1999, the Pancreatic Cancer Action Network (PanCAN) is a leading 501(c)(3) nonprofit organization dedicated to improving the lives of those affected by pancreatic cancer. PanCAN's mission encompasses advancing scientific research, building community, sharing knowledge, and advocating for patients. The organization is headquartered in Manhattan Beach, California, and operates with a nationwide network of volunteers and affiliates.

Key Strategic Focus

PanCAN's strategic objectives include:

Research Advancement: Funding groundbreaking research initiatives to transform pancreatic cancer detection and treatment.

Patient Support: Providing free, personalized information and resources to patients, caregivers, and healthcare professionals.

Community Engagement: Raising awareness and mobilizing communities through events like PurpleStride to support the cause.

Advocacy: Driving legislative support for increased federal research funding and policy changes to benefit pancreatic cancer patients.

These efforts are aimed at increasing survival rates and improving the quality of life for those impacted by pancreatic cancer.

Financials and Funding

For the fiscal year ending June 30, 2024, PanCAN reported:

Total Revenue: $47.1 million

Total Expenses: $60.5 million

Net Assets: $35.2 million

The organization's revenue sources included contributions, special events, clinical research contracts, and investment returns. Program expenses accounted for approximately 68% of total expenses, reflecting a strong commitment to mission-driven activities.

Pipeline Development

PanCAN's key initiatives include:

Precision Promise: An adaptive clinical trial platform launched in 2016 to accelerate the development of new treatments.

Early Detection Initiative: A study to determine if imaging at the time of new-onset diabetes can lead to earlier detection of pancreatic cancer.

Know Your Tumor®: A precision medicine service providing molecular profiling to inform personalized treatment options.

These programs are designed to advance research and improve patient outcomes.

Technological Platform and Innovation

PanCAN leverages advanced technologies to enhance its services:

Salesforce's Nonprofit Cloud: Implemented to streamline patient services, enabling faster information retrieval and improved case management.

Artificial Intelligence (AI): Utilized to analyze data, measure program impact, and optimize resource allocation.

These technological advancements support PanCAN's mission by improving efficiency and effectiveness in service delivery.

Leadership Team

PanCAN's leadership comprises experienced professionals dedicated to the organization's mission:

Julie Fleshman: President & CEO

Sudheer Doss: Chief Business Officer

Lynn Matrisian: Chief Science Officer

Anat Kendal: Chief Financial & Business Operations Officer

These leaders bring extensive expertise in nonprofit management, scientific research, and business operations.

Leadership Changes

As of the latest available information, there have been no recent significant changes in PanCAN's leadership team.

Competitor Profile

Market Insights and Dynamics

Pancreatic cancer is projected to become the second leading cause of cancer-related death in the U.S. around 2020. This underscores the critical need for research, patient support, and advocacy efforts.

Competitor Analysis

Key organizations in the pancreatic cancer space include:

Lustgarten Foundation for Pancreatic Cancer Research: A 501(c)(3) nonprofit dedicated to advancing research related to the diagnosis, treatment, cure, and prevention of pancreatic cancer.

These organizations contribute to the collective effort to combat pancreatic cancer through research funding, patient support, and advocacy.

Strategic Collaborations and Partnerships

PanCAN collaborates with various organizations to strengthen its impact:

World Pancreatic Cancer Coalition: A founding member of this coalition, PanCAN works with over 100 patient advocacy organizations from more than 30 countries to raise global awareness and support for pancreatic cancer.

Deadliest Cancers Coalition: Founded by PanCAN in 2008, this consortium focuses on policy issues related to the nation's most lethal cancers.

These partnerships enhance PanCAN's ability to advocate for increased research funding and policy changes.

Operational Insights

PanCAN's strategic initiatives, technological advancements, and collaborative efforts position the organization as a leader in the fight against pancreatic cancer. Its comprehensive approach, combining research funding, patient support, community engagement, and advocacy, differentiates PanCAN from other organizations in the field.